ID: MRFR/LS/4898-HCR | 90 Pages | Author: Kinjoll Dey | March 2024
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Assisted Reproductive Technology (ART) Market, by Diagnosis
6.1 Introduction
6.2 Ovulation Testing
6.3 Hysterosalpingography.
6.4 Ovarian Reserve Testing
6.5 Genetic Testing
6.6 Other hormone testing
6.7 Imaging tests
Chapter 7. Global Assisted Reproductive Technology (ART) Market, by Type
7.1 Introduction
7.2 Ovulation Induction (OI)
7.3 Artificial Insemination (AI)
7.4 Donor Conception
7.5 In-Vitro Fertilization (IVF)
7.6 Gamete Intrafallopian Transfer (GIFT)
7.7 Intracytoplasmic Sperm Injection (ICSI)
7.8 Preimplantation Genetic Diagnosis (PGD)
7.9 Surrogacy
Chapter 8. Global Assisted Reproductive Technology (ART) market, by End-User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgical Centers
8.4 Diagnostic Centers
8.5 Gynecology Centers
8.6 Feminist Health Centers
8.7 IVF Centers
Chapter 9. Global Assisted Reproductive Technology (ART) Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Cosmos Biomedical Limited
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 California Cryobank
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bloom IVF Centre
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Cryolab Ltd
11.4.1 Company Overview
11.4.2 Type/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Parallabs
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 OvaScience
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Anecova
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Merck KGaA
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 CooperSurgical Inc.
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Ferring Pharmaceuticals
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 European Sperm Bank
11.11.1 Overview
11.11.2 Type Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Irvine Scientific
11.12.1 Overview
11.12.2 Type Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Hamilton Throne Ltd
11.13.1 Overview
11.13.2 Type Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Microm Ltd
11.14.1 Overview
11.14.2 Type Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Others
Chapter 12 Appendix
LIST OF TABLES
Table 1 Assisted Reproductive Technology (ART) Market Industry Synopsis, 2023-2030
Table 2 Global Assisted Reproductive Technology (ART) Market Estimates & Forecast, 2023-2030, (USD Million)
Table 3 Global Assisted Reproductive Technology (ART) Market, by Region, 2023-2030, (USD Million)
Table 4 Global Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 5 Global Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 6 Global Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 7 North America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 8 North America Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 9 North America Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 10 US Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 11 US Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 12 US Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 13 Canada Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 14 Canada Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 15 Canada Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 16 South America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 17 South America Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 18 South America Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 19 Europe Assisted Reproductive Technology (ART) Market, Diagnosis, 2023-2030, (USD Million)
Table 20 Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 21 Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 22 Western Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 23 Western Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 24 Western Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 25 Eastern Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table26 Eastern Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 27 Eastern Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 28 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 29 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 30 Asia-Pacific Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
Table 31 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)
Table 32 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)
Table 33 Middle East & Africa Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Assisted Reproductive Technology (ART) Market
Figure 3 Market Dynamics for Global Assisted Reproductive Technology (ART) Market
Figure 4 Global Assisted Reproductive Technology (ART) Market Share, by Diagnosis 2020
Figure 5 Global Assisted Reproductive Technology (ART) Market Share, by Type 2020
Figure 6 Global Assisted Reproductive Technology (ART) Market Share, by End-User, 2020
Figure 7 Global Assisted Reproductive Technology (ART) Market Share, by Region, 2020
Figure 8 North America Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 9 Europe Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 10 Asia-Pacific Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 11 Middle East & Africa Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 12 Global Assisted Reproductive Technology (ART) Market: Company Share Analysis, 2020 (%)
Figure 13 COSMOS BIOMEDICAL LIMITED: Key Financials
Figure 14 COSMOS BIOMEDICAL LIMITED: Segmental Revenue
Figure 15 COSMOS BIOMEDICAL LIMITED: Geographical Revenue
Figure 16 California Cryobank: Key Financials
Figure 17 California Cryobank: Segmental Revenue
Figure 18 California Cryobank: Geographical Revenue
Figure 19 Bloom IVF Centre: Key Financials
Figure 20 Bloom IVF Centre: Segmental Revenue
Figure 21 Bloom IVF Centre: Geographical Revenue
Figure 22 Cryolab Ltd: Key Financials
Figure 23 Cryolab Ltd: Segmental Revenue
Figure 24 Cryolab Ltd: Geographical Revenue
Figure 25 OvaScience: Key Financials
Figure 26 OvaScience: Segmental Revenue
Figure 27 OvaScience: Geographical Revenue
Figure 28 Parallabs: Key Financials
Figure 29 Parallabs: Segmental Revenue
Figure 30 Parallabs: Geographical Revenue
Figure 31 Anecova. : Key Financials
Figure 32 Anecova. : Segmental Revenue
Figure 33 Anecova. : Geographical Revenue
Figure 34 Merck KGaA: Key Financials
Figure 35 Merck KGaA: Segmental Revenue
Figure 36 Merck KGaA: Geographical Revenue
Figure 37 CooperSurgical Inc.: Key Financials
Figure 38 CooperSurgical Inc.: Segmental Revenue
Figure 39 CooperSurgical Inc.: Geographical Revenue
Figure 40 Ferring Pharmaceuticals: Key Financials
Figure 41 Ferring Pharmaceuticals: Segmental Revenue
Figure 42 Ferring Pharmaceuticals: Geographical Revenue
Figure 46 Irvine Scientific .: Key Financials
Figure 47 Irvine Scientific .: Segmental Revenue
Figure 48 Irvine Scientific .: Geographical Revenue
Figure 49 Hamilton Throne Ltd: Key Financials
Figure 50 Hamilton Throne Ltd: Segmental Revenue
Figure 51 Hamilton Throne Ltd: Geographical Revenue
Figure 52 Microm Ltd: Key Financials
Figure 53 Microm Ltd: Segmental Revenue
Figure 54 Microm Ltd: Geographical Revenue
Assisted Reproductive Technology Market Segmentation
Assisted Reproductive Technology Diagnosis Outlook (USD Billion, 2019-2030)
Ovulation Testing
Hysterosalpingography
Assisted Reproductive Technology Type Outlook (USD Billion, 2019-2030)
Ovulation Induction
Artificial Insemination
Surrogacy
Assisted Reproductive Technology End-User Outlook (USD Billion, 2019-2030)
Hospitals
Clinics
IVF Center
Assisted Reproductive Technology Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
North America Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
North America Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
US Outlook (USD Billion, 2019-2030)
US Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
US Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
US Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
CANADA Outlook (USD Billion, 2019-2030)
CANADA Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
CANADA Assisted Reproductive TechnologyBy Type
Ovulation Induction
Artificial Insemination
Surrogacy
CANADA Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Europe Outlook (USD Billion, 2019-2030)
Europe Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Europe Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Europe Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Germany Outlook (USD Billion, 2019-2030)
Germany Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Germany Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Germany Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
France Outlook (USD Billion, 2019-2030)
France Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
France Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
France Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
UK Outlook (USD Billion, 2019-2030)
UK Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
UK Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
UK Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
ITALY Outlook (USD Billion, 2019-2030)
ITALY Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
ITALY Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
ITALY Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
SPAIN Outlook (USD Billion, 2019-2030)
Spain Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Spain Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Spain Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
REST OF EUROPE Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
REST OF EUROPE Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Asia-Pacific Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Asia-Pacific Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
China Outlook (USD Billion, 2019-2030)
China Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
China Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
China Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Japan Outlook (USD Billion, 2019-2030)
Japan Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Japan Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Japan Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
India Outlook (USD Billion, 2019-2030)
India Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
India Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
India Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Australia Outlook (USD Billion, 2019-2030)
Australia Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Australia Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Australia Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Rest of Asia-PacificOutlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Rest of Asia-Pacific Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Rest of Asia-Pacific Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Rest of the World Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Rest of the World Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Middle East Outlook (USD Billion, 2019-2030)
Middle East Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Middle East Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Middle East Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Africa Outlook (USD Billion, 2019-2030)
Africa Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Africa Assisted Reproductive Technology By Type
Ovulation Induction
Artificial Insemination
Surrogacy
Africa Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Latin America Outlook (USD Billion, 2019-2030)
Latin America Assisted Reproductive Technology By Diagnosis
Ovulation Testing
Hysterosalpingography
Latin America Assisted Reproductive TechnologyBy Type
Ovulation Induction
Artificial Insemination
Surrogacy
Latin America Assisted Reproductive Technology by End User
Hospitals
Clinics
IVF Center
Research Methodology on Assisted Reproductive Technology Market
Introduction
This research proposes to study the global assisted reproductive technology (ART) market. The objective of this research is to provide a comprehensive analysis of the market size, share, and dynamics of the industry. Secondary as well as primary research methods and techniques are applied to determine the exact size and growth trends. The global assisted reproductive technology market is segmented based on types, applications and services.
Research Objectives
The general objective of this research is to analyze the size, structure and growth of the global assisted reproductive technology market. The research focuses on the following objectives:
Research Approach
The global assisted reproductive technology market is studied using both primary and secondary research methodologies. The study uses a combined approach of both quantitative and qualitative data analysis. Top-down and bottom-up approaches are used for the estimation and projection of the market size. Data such as market size, product types, applications, services and market segmentations have been collected from secondary sources such as industry reports, whitepapers and commercial databases, and primary sources such as interviews, surveys and in-depth analysis from industry experts.
Secondary Data
To understand the global assisted reproductive technology market, the report uses extensive secondary research. The report uses data such as market size, industry outlook and trends, applications, service providers, regulations and government incentives. The report also uses internal and external proprietary databases. The sources used to collect data include industry magazines, Internet searches, databases and financial statements.
Primary Data
For a deeper and more accurate understanding of the trends and dynamics, the report also employs primary research by interviewing industry professionals and stakeholders. Primary research includes interviews with industry experts and professionals. Experts from various industries and different countries are contacted to get their opinion on the global assisted reproductive technology market. Primary research includes surveys, email interactions and direct interviews with experts. The primary research provides a better understanding of the market trends, dynamics and any other insights that require in-depth analysis.
Data Analysis and Projection
All the data collected from both primary and secondary sources is analysed to provide an accurate overall picture of the market. The data is then used to project the market size and segmentation. Both top-down and bottom-up approaches are used to estimate the market size and metrics. Furthermore, the projection is also identified using regression analysis, ARIMA and ARMA models.